# Effect of Lithium Therapy on Long COVID Symptoms

> **NCT05618587** · PHASE2 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 52 (actual)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** Lithium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05618587
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-28
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-07-21
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618587, "Effect of Lithium Therapy on Long COVID Symptoms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05618587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*